The COMPLETE Treatment of Bifurcation With Two-stent Techniques: Randomized Comparison of Crush Versus Culotte Technique

NCT ID: NCT05488665

Last Updated: 2024-10-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

512 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-11-10

Study Completion Date

2028-09-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this COMPLETE randomized trial, using the contemporary second-generation drug-eluting stent, we aimed to test whether the crush technique is superior to the culotte technique for the treatment of bifurcation lesions in terms of 1-year target-lesion failure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Crush technique group

Two stenting with the Crush technique

Group Type EXPERIMENTAL

Crush technique

Intervention Type DEVICE

Treatment for bifurcation with the Crush technique

Culotte technique group

Two stenting with the Culotte technique

Group Type ACTIVE_COMPARATOR

Culotte technique

Intervention Type DEVICE

Treatment for bifurcation with the culotte technique

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Crush technique

Treatment for bifurcation with the Crush technique

Intervention Type DEVICE

Culotte technique

Treatment for bifurcation with the culotte technique

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age ≥19 years
2. De novo coronary lesions eligible for drug-eluting stent implantation
3. Medina 1,1,1 or 1,0,1 or 0,1,1 de novo bifurcation lesions (LM or non-LM) and those of main vessel or side branch can be covered by 2 stents
4. Reference vessel diameter of side branch ≥2.5 mm by visual estimation

Exclusion Criteria

1. Current or potential pregnancy
2. Inability to follow the patient over the period of 1 year after enrollment, as assessed by the investigator
3. Subjects with ST elevation myocardial infarction \<24 h from the onset of chest pain
4. Cardiogenic Shock
Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Yonsei University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Byeong-Keuk Kim, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Yonsei University Health System, Severance Hospital

Seoul, , South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Byeong-Keuk Kim, MD, PhD

Role: CONTACT

82-02-2228-8465

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Byeong-Keuk Kim, MD, PhD

Role: primary

82-02-2228-8465

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1-2022-0033

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

The Nordic-Baltic Bifurcation Study IV
NCT01496638 ACTIVE_NOT_RECRUITING NA